CN107050044A - Medical application of the grey meat Russula polysaccharide in systemic lupus erythematosus - Google Patents

Medical application of the grey meat Russula polysaccharide in systemic lupus erythematosus Download PDF

Info

Publication number
CN107050044A
CN107050044A CN201710537645.2A CN201710537645A CN107050044A CN 107050044 A CN107050044 A CN 107050044A CN 201710537645 A CN201710537645 A CN 201710537645A CN 107050044 A CN107050044 A CN 107050044A
Authority
CN
China
Prior art keywords
polysaccharide
grey
ultra
pure water
preferred
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710537645.2A
Other languages
Chinese (zh)
Other versions
CN107050044B (en
Inventor
孟兆丽
陈倩
初晓
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jilin University
Original Assignee
Jilin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jilin University filed Critical Jilin University
Priority to CN201710537645.2A priority Critical patent/CN107050044B/en
Publication of CN107050044A publication Critical patent/CN107050044A/en
Application granted granted Critical
Publication of CN107050044B publication Critical patent/CN107050044B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/15Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/53Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/55Liquid-liquid separation; Phase separation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Sustainable Development (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

There is regulatory T-cell subgroup activity the invention discloses the grey meat Russula polysaccharide PRG1 2 of medical application of the grey meat Russula polysaccharide in systemic lupus erythematosus, IL 10, ds DNA antibodies and Urine proteins are reduced, it is evident in efficacy, it is safe and reliable.The present invention for ash meat Russula polysaccharide PRG1 2 in preparation system lupus erythematosus application, with wide potential applicability in clinical practice.

Description

Medical application of the grey meat Russula polysaccharide in systemic lupus erythematosus
Technical field
The invention discloses medical application of the grey meat Russula polysaccharide in systemic lupus erythematosus, there is provided ash is flesh-coloured The new medical application of mushroom polysaccharide, belongs to pharmaceutical technology field.
Background technology
Systemic loupus erythematosus(Systemic Lupus Erythematosus, SLE)It is a kind of common itself of clinic Immunity disease, is produced, complement activation and immune complex deposit is major pathologic features using autoantibody.The master of SLE morbidities It is exactly that autoimmune tolerance is abnormal to want feature, therefore immunology factor is paid attention to extensively.Research shows, patient's SLE peripheral blood CD3 + CD4+T cells decline, and CD3+CD8+ rises, the up-regulation of IL-10 levels.IL-10 has immunostimulation and the dual work of immunosupress With.There are some researches show IL-10 stimulating system patients with SLE PBMCs is produced in Anti-hCG action, SLE patient's body Level is all significantly higher than healthy population in active stage and paracmasis.The Chinese SLE incidence of disease is 0.31%-0.70%, the course of disease It is long, delay repeatedly, disability rate is high, harm to the human body is very big.Because the SLE causes of disease and pathogenesis are still not clear, thus it is right at present SLE treatment not fully effective method, can only clinical remission can not cure.At present, treatment SLE main method is sharp Plain therapy, but Long-term Hormone side effect is big, and hormone subtracts and stops most likely resulting in aggravation.Therefore, one is found Planting new natural drug treatment SLE has very important realistic meaning and application prospect.
The flesh-coloured mushroom of ash(Russula griseocarnosa)It was registered as newly in China first by Wang Xianghua in 2009 Kind, and grey flesh-coloured mushroom is named as first.Originally the flesh-coloured mushroom of ash is mistaken as Russula vinosa(Russula vinosa), there is no at present People isolates strain.Russula Basidiomycotina, Hymenomycetes, russule mesh, Russulaceae, Russula is a class macro fungi." this Careless detailed outline " is contained, and russule taste is clear, warm-natured, appetizing, antidiarrheal, removing toxic substances, nourishing, informal dress lengthen one's life." legendary god of farming's book on Chinese herbal medicine " is recorded, red Mushroom can be used for treatment eyes to fail to understand, can purging the liver of pathogenic fire through fire, radiating has a respite.Modern science and technology research also indicates that grey flesh-coloured mushroom has There are multiple pharmacological effect such as antibacterial action, antioxidation, improve anaemia, clearing damp strengthens immunity of organisms, prevents heart disease, Hypoglycemic, blood fat and anti-cancer function.
At present, China receives significant attention on the research of edible and medical fungi polysaccharide, due to its efficient, natural, nontoxic secondary work Wide research and application prospect are shown with feature.Vast territory and abundant resources for China, and a large amount of edible and medical fungis are urgently developed.Had no through retrieval Medical application file report of the grey meat Russula polysaccharide in systemic lupus erythematosus disease.
The content of the invention
It is flesh-coloured with ash the invention discloses a kind of medical application of grey meat Russula polysaccharide in systemic lupus erythematosus Mushroom dry product raw material, a kind of grey meat Russula polysaccharide is obtained using special extracting method and effective way of purification(Referred to as: PRG1- 2), the medicine for preparing systemic lupus erythematosus.
It is an object of the invention to provide a kind of preparation method of grey meat Russula polysaccharide, comprise the following steps:
1)Crush grey flesh-coloured massee fruiting bodies:
Wild grey flesh-coloured massee fruiting bodies are dried to quality and no longer changed, are crushed using crusher, and carry out 100 mesh sieve mistakes Filter, sealing preserve is used to extract polysaccharide;
2)Water extraction extracts Thick many candies:
Ultra-pure water is added to grey flesh-coloured massee fruiting bodies powder, is extracted in high temperature bath after a period of time, leaching liquor is filtered with double-deck Paper is filtered, and gained filtrate is leaching liquor, and leaching liquor is concentrated into the 1/20 of initial volume using Rotary Evaporators;It is preferred that, weigh 40 g steps 1)Middle obtained powder;It is preferable in 90 DEG C of water-baths and extracts;It is preferred that, extract 3 h;It is preferred that, leaching liquor is concentrated into 50 mL;
3)Alcohol precipitation:
The absolute ethyl alcohol of 4 times of volume of concentrate is added into concentrate and is fully mixed, stands overnight, retains under the conditions of 4 DEG C Precipitation, and it is abundant using the washing of 75 % ethanol, precipitation is lyophilized standby;It is preferred that, 4 DEG C of standing 12h;
4)Sevage method deproteinizeds:
By step 3)Gained sediment is dissolved using ultra-pure water, is separately added into isometric n-butanol:Chloroform(1:4)Mixed solution Afterwards, centrifuge, retain supernatant, altogether in triplicate;It is preferred that, 2000 g centrifugations 20min;
5)Dialysis:
By step 4)After gained polysaccharide ultra-pure water dissolves, after being dialysed in ultra-pure water, freeze;
6)Alcohol precipitation:
By step 5)Polysaccharide sample is dissolved with ultra-pure water again, centrifuging and taking supernatant, then with the ethanol alcohol precipitation of final concentration 80%, centrifugation is gone Supernatant, precipitation is lyophilized standby;It is preferred that, 5000rpm is used after ultra-pure water dissolving, 10 min is centrifuged, takes supernatant;It is preferred that, After 80% ethanol alcohol precipitation, using 5000rpm, 10 min are centrifuged;
7)Cation exchange chromatography:
By 6)Alcohol precipitation sample dissolves the Thick many candies for obtaining grey flesh-coloured massee fruiting bodies using ultra-pure water, using ultrapure water balance DEAE- 52 posts, the slow loading of Thick many candies solution is first eluted with water, neutral sugar is got rid of, then be respectively adopted containing 0.1,0.2,0.3 The M NaCl aqueous solution elutes pillar, collects the sample under the elution of the 0.2 M NaCl aqueous solution;
8)Sieve chromatography is purified:
Using 0.2M NaCl aqueous equilibrium molecular sieves, the polysaccharide sample under being eluted containing the 0.2 M NaCl aqueous solution is carried out Sephadex G100 molecular sieve column chromatographies, and eluted using the 0.2 M NaCl aqueous solution, first eluting peak is collected, i.e., Obtain PRG1-2.
The positive effect of the present invention is:
There is provided grey meat Russula polysaccharide in the new medical application of systemic lupus erythematosus disease, by animal model test, Grey meat Russula polysaccharide has regulatory T-cell subgroup activity, IL-10, ds-DNA antibody and Urine proteins effect is reduced, for systematicness The treatment of lupus erythematosus has evident in efficacy, safe and reliable, the features such as toxic side effect is small, be the treatment of systemic loupus erythematosus again There is provided a kind of new medicine.
Brief description of the drawings
Fig. 1 is the flesh-coloured mushroom Thick many candies of DEAE chromatographies of the present invention ash;
Fig. 2 is that sieve chromatography of the present invention separates grey meat Russula polysaccharide PRG1.
Embodiment
The embodiment of the present invention is used for that the composition of the present invention is further described, rather than to the present invention's Limitation.
Embodiment 1
The preparation method of the flesh-coloured massee fruiting bodies Thick many candies of ash, is followed the steps below successively:
1)The grey flesh-coloured massee fruiting bodies for plucking fresh are dried to quality and no longer changed, moisture removal is thoroughly removed;
2)Using the fructification of crusher crushing drying, cross 100 mesh sieves and remove larger particles;
3)The flesh-coloured massee fruiting bodies powder of 40 g ashes is weighed, 1L ultra-pure waters is added, 3 h is extracted in 90 DEG C of water-bath.By leaching liquor Filtered with double-layer filter paper, gained filtrate is leaching liquor, and leaching liquor is concentrated into 50 mL using Rotary Evaporators;
4)The absolute ethyl alcohol of 4 times of volume of concentrate is slowly added into concentration leaching liquor and is fully mixed,
40 DEG C of standing 12-16 h, retain precipitation, and use 75 % ethanol to be freezed after fully washing;
5)Sediment is resuspended with 10 mL ultra-pure waters and dissolved, with 10 mL n-butanols, chloroform mixed liquor(N-butanol:Chloroform=4:1) Under mixing, normal temperature, fully shaking, 3000 g centrifuge 20 min, take upper strata aqueous phase, this step is repeated 3 times;
6)By step(5)After aqueous sample ultra-pure water dissolves, after being dialysed in ultra-pure water, freeze;
7)By step(6)Use ultra-pure water dissolves polysaccharide sample again, and 5000rpm, 10 min of centrifugation take supernatant, then dense with end 80% ethanol alcohol precipitation is spent, 5000rpm, 10 min of centrifugation remove supernatant, and precipitation is lyophilized standby.
Embodiment 2
The flesh-coloured plant mushroom fruit body polysaccharide PRG1-2 of ash isolation and purification method, is followed the steps below successively:
1)Ion-exchange chromatography:Grey flesh-coloured mushroom Thick many candies freeze-dried powder, 0.22 μM of membrane filtration are resuspended using ultra-pure water.Adopt in advance With ultrapure water balance DEAE-52 posts, by Thick many candies solution with the slow upper prop of 1mL/min speed, the milli-Q water of 2 times of column volumes Pillar, then be respectively adopted containing 0.1M NaCl, 0.2 M NaCl and 0.3M the NaCl aqueous solution is washed with 1.0mL/min flow velocity De- pillar, and all polysaccharide samples eluted are collected, 0.2 M NaCl are eluted into lower sample P RG1 carries out next step purifying;
2)The PRG1 of previous step is carried out into molecular sieve to isolate and purify.Use first and contain 0.2 M NaCl aqueous equilibriums Sephadex G100, PRG1 loadings are eluted with 1 mL/min flow velocitys, and it is PRG1-2 to collect second eluting peak.
Further prove grey meat Russula polysaccharide in the new medical of systemic lupus erythematosus disease by following zoopery Purposes:
Influences of the flesh-coloured massee fruiting bodies purified polysaccharide PRG1-2 of ash to systemic loupus erythematosus MRL/lpr mouse:
1st, 40 8 week old SLE female MRL/lpr mouse are randomly divided into following 4 groups, every group 10, daily gastric infusion connects Continuous administration 3 weeks;
2nd, mice serum IL-10 and ds-DNA level is determined:
Using IL-10 mouse ELISA kit (Invitrogen) and Mouse dsDNA ELISA Kit(Creative Diagnostics)IL-10 and ds-DNA antibody levels in each group mice serum after measure is administered 3 weeks;
3rd, mouse boosting cell T cell subgroup (CD3 is determined+CD4+, CD3+CD8+):
Splitting erythrocyte processing is carried out using Mechanical Method separating mouse splenocyte, and to it, will using 2% FBS PBS Cell concentration is adjusted to 2 × 106Cells/mL, every mouse prepares two sample cells, and often the μ L of pipe 100, are added by following form Enter streaming antibody(BD Biosciences).Room temperature lucifuge is incubated 30min, using the FBS of 1mL 2% PBS(500g, 5min)Washing, and be resuspended using the FBS of 500 μ L 2% PBS, for flow cytometer detection;
4)Mouse urine protein level is determined:
Using Urine proteins detection kit(Beijing Strong Biotechnologies, Inc.)Determine each group mouse retention after being administered 3 weeks Protein level;
5)Experimental result:
Compared with SLE control mice groups(Table 1), PRG1-2 administration groups can significantly reduce IL-10, ds-DNA antibody and Urine proteins Level, and with the increase of PRG1-2 dosage, IL-10, ds-DNA antibody and urine protein level reduction are more notable, this explanation present invention It is notable for SLE mouse therapeutic effects;
Influences of the PRG1-2 of table 1 to SLE mice serums IL-10, ds-DNA and urine protein level:
In addition, T cell subgroup analysis result shows, compared with SLE control mice groups(Table 2), after gastric infusion PRG1-2, give The CD3 of medicine group mouse+CD4+Subset proportions rise in dose dependent fashion, and the CD3 of administration group mouse+CD8+Subset proportions are in Dose dependent fashion declines, with the effect for correcting SLE mouse T cell subset proportions imbalance states.
Influences of the PRG1-2 of table 2 to SLE mice serums IL-10, ds-DNA and urine protein level
Conclusion, PRG1-2 has reduction SLE mouse IL-10, ds-DNA, a Urine proteins effect, and it is unbalance to correct T cell subgroup, Illustrate that the PRG1-2 prepared by the present invention treats SLE mouse effect significantly, the medicine available for systemic lupus erythematosus In application.

Claims (2)

1. a kind of application of grey meat Russula polysaccharide in the medicine of systemic lupus erythematosus is prepared.
2. a kind of preparation method of grey meat Russula polysaccharide, comprises the following steps:
1)Crush grey flesh-coloured massee fruiting bodies:
Wild grey flesh-coloured massee fruiting bodies are dried to quality and no longer changed, are crushed using crusher, and carry out 100 mesh sieve mistakes Filter, sealing preserve is used to extract polysaccharide;
2)Water extraction extracts Thick many candies:
Ultra-pure water is added to grey flesh-coloured massee fruiting bodies powder, is extracted in high temperature bath after a period of time, leaching liquor is filtered with double-deck Paper is filtered, and gained filtrate is leaching liquor, and leaching liquor is concentrated into the 1/20 of initial volume using Rotary Evaporators;It is preferred that, weigh 40 g steps 1)Middle obtained powder;It is preferable in 90 DEG C of water-baths and extracts;It is preferred that, extract 3 h;It is preferred that, leaching liquor is concentrated into 50 mL;
3)Alcohol precipitation:
The absolute ethyl alcohol of 4 times of volume of concentrate is added into concentrate and is fully mixed, stands overnight, retains under the conditions of 4 DEG C Precipitation, and it is abundant using the washing of 75 % ethanol, precipitation is lyophilized standby;It is preferred that, 4 DEG C of standing 12h;
4)Sevage method deproteinizeds:
By step 3)Gained sediment is dissolved using ultra-pure water, is separately added into isometric n-butanol:Chloroform(1:4)Mixed solution Afterwards, centrifuge, retain supernatant, altogether in triplicate;It is preferred that, 2000 g centrifugations 20min;
5)Dialysis:
By step 4)After gained polysaccharide ultra-pure water dissolves, after being dialysed in ultra-pure water, freeze;
6)Alcohol precipitation:
By step 5)Polysaccharide sample is dissolved with ultra-pure water again, centrifuging and taking supernatant, then with the ethanol alcohol precipitation of final concentration 80%, centrifugation is gone Supernatant, precipitation is lyophilized standby;It is preferred that, 5000rpm is used after ultra-pure water dissolving, 10 min is centrifuged, takes supernatant;It is preferred that, After 80% ethanol alcohol precipitation, using 5000rpm, 10 min are centrifuged;
7)Cation exchange chromatography:
By 6)Alcohol precipitation sample dissolves the Thick many candies for obtaining grey flesh-coloured massee fruiting bodies using ultra-pure water, using ultrapure water balance DEAE- 52 posts, the slow loading of Thick many candies solution is first eluted with water, neutral sugar is got rid of, then be respectively adopted containing 0.1,0.2,0.3 The M NaCl aqueous solution elutes pillar, collects the sample under the elution of the 0.2 M NaCl aqueous solution;
8)Sieve chromatography is purified:
Using 0.2M NaCl aqueous equilibrium molecular sieves, the polysaccharide sample under being eluted containing the 0.2 M NaCl aqueous solution is carried out Sephadex G100 molecular sieve column chromatographies, and eluted using the 0.2 M NaCl aqueous solution, first eluting peak is collected, i.e., Obtain PRG1-2.
CN201710537645.2A 2017-07-04 2017-07-04 Purposes of the grey meat Russula polysaccharide in the drug for preparing systemic lupus erythematosus Expired - Fee Related CN107050044B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710537645.2A CN107050044B (en) 2017-07-04 2017-07-04 Purposes of the grey meat Russula polysaccharide in the drug for preparing systemic lupus erythematosus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710537645.2A CN107050044B (en) 2017-07-04 2017-07-04 Purposes of the grey meat Russula polysaccharide in the drug for preparing systemic lupus erythematosus

Publications (2)

Publication Number Publication Date
CN107050044A true CN107050044A (en) 2017-08-18
CN107050044B CN107050044B (en) 2019-11-22

Family

ID=59613838

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710537645.2A Expired - Fee Related CN107050044B (en) 2017-07-04 2017-07-04 Purposes of the grey meat Russula polysaccharide in the drug for preparing systemic lupus erythematosus

Country Status (1)

Country Link
CN (1) CN107050044B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112569336A (en) * 2020-12-16 2021-03-30 广东省微生物研究所(广东省微生物分析检测中心) Application of grifola frondosa glycoprotein in preparation of drugs or health foods for enhancing body immunity and preventing and/or treating tumor diseases

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104666902A (en) * 2013-11-28 2015-06-03 青岛食之礼中草药研究所 Traditional Chinese medicine for treating lupus erythematosus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104666902A (en) * 2013-11-28 2015-06-03 青岛食之礼中草药研究所 Traditional Chinese medicine for treating lupus erythematosus

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
YE YUAN,ET AL.,: "Optimization extraction and bioactivities of polysaccharide from wild Russula griseocarnosa", 《SAUDI PHARMACEUTICAL JOURNAL》 *
张云波等: "红菇的药理作用研究进展", 《中国药业》 *
徐涛等: "黄芪多糖对系统性红斑狼疮患者血中T细胞效应功能的研究", 《中国伤残医学》 *
陈新华: "广东商品红菇形态和分子鉴定、营养成分分析及其生物活性研究", 《中国博士学位论文全文数据库农业科技辑》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112569336A (en) * 2020-12-16 2021-03-30 广东省微生物研究所(广东省微生物分析检测中心) Application of grifola frondosa glycoprotein in preparation of drugs or health foods for enhancing body immunity and preventing and/or treating tumor diseases
CN112569336B (en) * 2020-12-16 2023-08-11 广东省微生物研究所(广东省微生物分析检测中心) Application of russula cinerea glycoprotein in preparation of medicines or health foods for enhancing organism immunity and preventing and/or treating tumor diseases

Also Published As

Publication number Publication date
CN107050044B (en) 2019-11-22

Similar Documents

Publication Publication Date Title
CN102585029B (en) Preparation method and application of physiologically active notoginseng polysaccharide
CN101721567B (en) Grassleaf sweetflag rhizome extract, preparation method and application thereof
CN102260660B (en) Queen bee intestinal enzyme and preparation method and application thereof
CN106943423A (en) The polysaccharide composition acted on regulating intestinal canal Bacterial community and its application
CN105148258A (en) Composition and application thereof, and preparation containing composition
CN114224978B (en) Traditional Chinese medicine compound composition with anti-fatigue function and application thereof
CN106084087A (en) A kind of preparation method of Fructus Trichosanthis polysaccharide
CN107812016B (en) Periplaneta americana extract, preparation method and application thereof in immune regulation
CN102416027A (en) Gingkgo active ingredient extraction and separation method and use of extracted active matters in medicines for treating cardiovascular and cerebrovascular diseases
CN102894152B (en) Health-care tea and preparation method thereof
CN107050044B (en) Purposes of the grey meat Russula polysaccharide in the drug for preparing systemic lupus erythematosus
CN105079143A (en) Medicine composition for treating nephropathy
CN101948549B (en) Sulphating modification method of gynostemma pentaphylla polysaccharide
CN105906737A (en) Huidouba polysaccharide and preparation method thereof
CN106496346A (en) A kind of isolation and purification method of white polysaccharide
CN104403016B (en) A kind of mulberry leaf polysaccharide and preparation method for separating and purifying thereof and application
CN106188258A (en) A kind of method extracting Radix Polygalae glycoprotein
CN103735621A (en) Chinese medicinal composition with blood lipid reducing and immunity enhancing effects
CN103479875A (en) Preparation method and application of high-activity radix polygonati officinalis concentrated solution
CN103467616B (en) A kind of preparation method of antiallergic porphyra polysaccharide
CN104546988A (en) Preparation method of trichosanthes kirilowii Maxim polysaccharide immunopotentiator
CN106749742B (en) Polysaccharides in Cultured Cordyceps militaris, extracting method and its application in terms of functional consitipation drug is treated in preparation
CN110038043A (en) A kind of pueraria lobata toxin expelling nutrient powder and its preparation method and application
CN106619972A (en) Hirsutella hepiali chen et shen mycelium powder hypoglycemic capsule and preparation method and application thereof
CN105294879B (en) A kind of ramulus mori antitumor activity polysaccharide RMPW 2 preparation method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20191122

Termination date: 20200704